The role of routine cardiac investigations before hyperbaric oxygen treatment
Authors:   Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, Ontario, Canada, Brenna Connor TA ,   Department of Physiology, University of Toronto, Toronto, Ontario, Canada, Salvatori Marcus ,   Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, Ontario, Canada,   Hyperbaric Medicine Unit, Toronto General Hospital, Toronto, Ontario, Canada,   Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada, Khan Shawn ,   Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, Ontario, Canada, Djaiani George ,   Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, Ontario, Canada,   Hyperbaric Medicine Unit, Toronto General Hospital, Toronto, Ontario, Canada,   Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada, Schiavo Simone ,   Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, Ontario, Canada,   Hyperbaric Medicine Unit, Toronto General Hospital, Toronto, Ontario, Canada,   Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada, Katznelson Rita ,   Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, Ontario, Canada,   Hyperbaric Medicine Unit, Toronto General Hospital, Toronto, Ontario, Canada,   Department of Anesthesia and Pain Management, University Health Network, Toronto, Ontario, Canada
Published: June 2024

Cardiac complications are a rare but potentially serious consequence of hyperbaric oxygen treatment (HBOT), resulting from increased blood pressure and decreased heart rate and cardiac output associated with treatment. These physiologic changes are generally well-tolerated by patients without preexisting cardiac conditions, although those with known or undetected cardiac disease may be more vulnerable to treatment complications. Currently, there are no universally accepted guidelines for pre-HBOT cardiac screening to identify these patients at heightened risk, leading to variability in practice patterns. In the absence of HBOT-specific evidence, screening protocols might be adapted from the diving medicine community; however, given the important differences in physiological stressors, these may not be entirely applicable to patients undergoing HBOT. Traditional cardiac investigations such as electro- and echo-cardiograms are limited in their ability to detect relevant risk modifying states in the pre-HBOT patient, stymieing their cost-effectiveness as routine tests. In the absence of strong evidence to support routine cardiac investigation, we argue that a comprehensive history and physical exam – tailored to identify high-risk patients based on clinical parameters – may serve as a more practical screening tool. While certain unique patient groups such as those undergoing dialysis or with implanted cardiac devices may warrant specialised assessment, thorough evaluation may be sufficient to identify many patients unlikely to benefit from cardiac investigation in the pre-HBOT setting. A clinical decision-making tool based on suggested low-risk and high-risk features is offered to guide the use of targeted cardiac investigation prior to HBOT.